Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2025-12-24 @ 7:38 PM
NCT ID: NCT02036203
Eligibility Criteria: Inclusion Criteria: \* Adult females aged 25-42 * Free and willing to fully comply with treatment process * Healthy women seeking LARC * Married or in a steady relationship (at least 1 year) * Blood hemoglobin \>11.5gr% * Signed informed consent form * If took COCP at least had one cycle after use of OC Exclusion Criteria(major) * Use IUB/IUD as an emergency contraception * A previously placed IUD that has not been removed * Pregnancy or suspicion of pregnancy * Use of other contraception method (condom for either male or female, oral contraceptives, diaphragms, spermicides, hormonal patches, injections or ring, cervical cap) * History of pelvic inflammatory disease, recent or remote. * Postpartum endometritis or post abortal endometritis in the past 3 month * Mucopurulent cervicitis * Endometrial thickness more than 12 mm on insertion date * Known anemia * History of previous IUD complications * Dysfunctional uterine bleeding * Undiagnosed uterine bleeding * Malignancy or suspected malignant disease of female inner or outer genitalia * Distortions of the uterine cavity by uterine fibroids or known anatomical abnormalities * Known intolerance or allergy to nitinol or copper and/or copper IUDs - Wilson's disease. * Medication that may interfere with the subject's ability to complete the protocol * Use of injectable contraception in the previous year * Any other significant disease or condition that could interfere with the subject's ability to complete the protocol * A history of alcohol or drug abuse * Known infection with human immunodeficiency virus (HIV), Hepatitis B or Hepatitis C * Pregnancy or pregnancy planned during the year * Enrollment (less than 30 days after completing another study) in or planned to be enrolled in another study
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 25 Years
Maximum Age: 42 Years
Study: NCT02036203
Study Brief:
Protocol Section: NCT02036203